Skip to main content
Computational and Mathematical Methods in Medicine logoLink to Computational and Mathematical Methods in Medicine
. 2019 Mar 12;2019:9089856. doi: 10.1155/2019/9089856

Bayesian Analysis of Three-Parameter Frechet Distribution with Medical Applications

Kamran Abbas 1, Nosheen Yousaf Abbasi 2, Amjad Ali 3,, Sajjad Ahmad Khan 3, Sadaf Manzoor 3, Alamgir Khalil 4, Umair Khalil 5, Dost Muhammad Khan 5, Zamir Hussain 6, Muhammad Altaf 7
PMCID: PMC6434294  PMID: 30992712

Abstract

The medical data are often filed for each patient in clinical studies in order to inform decision-making. Usually, medical data are generally skewed to the right, and skewed distributions can be the appropriate candidates in making inferences using Bayesian framework. Furthermore, the Bayesian estimators of skewed distribution can be used to tackle the problem of decision-making in medicine and health management under uncertainty. For medical diagnosis, physician can use the Bayesian estimators to quantify the effects of the evidence in increasing the probability that the patient has the particular disease considering the prior information. The present study focuses the development of Bayesian estimators for three-parameter Frechet distribution using noninformative prior and gamma prior under LINEX (linear exponential) and general entropy (GE) loss functions. Since the Bayesian estimators cannot be expressed in closed forms, approximate Bayesian estimates are discussed via Lindley's approximation. These results are compared with their maximum likelihood counterpart using Monte Carlo simulations. Our results indicate that Bayesian estimators under general entropy loss function with noninformative prior (BGENP) provide the smallest mean square error for all sample sizes and different values of parameters. Furthermore, a data set about the survival times of a group of patients suffering from head and neck cancer is analyzed for illustration purposes.

1. Introduction

Frechet distribution (FD) was introduced by Maurice Frechet (1878–1973) for largest extremes [1]. It had been derived with nonnegative initial variates. The FD deals with extreme events and also recognized as extreme value Type-II distribution. The cumulative distribution function of three-parameter FD is

Fx;α,λ,η=expxηλα,x>0,α,λ>0,η,, (1)

where α is the shape, λ is the scale, and η is the location parameter. If η=0 then it becomes two-parameter FD. The corresponding probability density function is

fx;α,λ,η=αλxηλα+1expxηλα. (2)

A number of authors have studied the estimation of its parameters, namely, Gumbel [2], Mann [3], Singh [4], and Hooda et al. [5]. Moreover, Afify [6] estimated the parameters of FD using principal components and least median of squares. Mubarak [7, 8] derived the best linear unbiased estimators and the best linear invariant estimators of location and scale parameters of FD under progressive Type-II censoring, respectively. Abbas and Tang [9] discussed classical as well as the Bayesian estimators of FD assuming that the shape parameter was known. Abbas and Tang [10] developed maximum likelihood and least squares estimators for FD with Type-II censored samples. Furthermore, Abbas and Tang [11, 12] derived the reference and matching priors for the Frechet stress-strength model and developed Bayesian estimators for FD under reference prior, respectively. Nasir and Aslam [13] obtained Bayes estimators of FD and their risks by using four loss functions under Gumbel Type-II prior and Levy prior. Yet, the Bayesian analysis of three-parameter FD is not conducted.

The aim of this paper is to develop Bayesian estimators for three-parameter FD using noninformative prior and gamma prior under two loss functions for the case of complete samples. Including this introduction section, the rest of the paper unfolds as follows: in Section 2, maximum likelihood estimators (MLEs) for the parameters are obtained. In Section 3, Bayesian estimators based on different loss functions by taking noninformative and gamma priors are derived. The proposed estimators are compared in terms of their mean squared error (MSE) in Section 4. Section 5 illustrates the applications of proposed estimators using head and neck cancer data set. Finally, conclusions and recommendations are presented in Section 6.

2. Maximum Likelihood Estimation

Let X 1, X 2,…, X n be random samples of size n from a three-parameter FD, then the likelihood function of (2) is

Łx¯;α,λ,η=i=1nαλXηλα+1expXηλα. (3)

The corresponding log-likelihood function is

Ł=log Łx¯;α,λ,η=n logα+nα logλα+1i=1nlogxiηi=1nxiηλα, (4)

from equation (4), we have

Łα=nα+n logλi=1nlogxiη+i=1nxiηλα×logxiηλ=0,Łλ=nαλαλi=1nxiηλα=0,Łη=α+1i=1nxiη1αλi=1nxiηλα1=0. (5)

Clearly, the above equations cannot be written in a closed form. Therefore, BFGS quasi-Newton optimization method (Broyden Fletcher GoldFarb Shanno, Battiti, and Masulli [14]) is applied to compute the MLEs.

3. Bayesian Estimation

In Bayesian estimation, we consider the two types of loss functions. The first is LINEX loss function, introduced by Varian [15]. This loss function was widely used by several authors, for example, Rojo [16], Basu and Ebrahimi [17], Pandey [18], Soliman [19], and Soliman et al. [20]. The second is general entropy loss function (GELF), defined by Calabria and Pulcini [21]. For Bayesian analysis, we need prior distribution. When prior information about the parameters is unavailable, then the noninformative prior can be considered for the Bayesian study. So, we supposed the noninformative form of priors for the all unknown parameters α, λ, and η of three-parameter FD as

πα,λ,η1αλη,α,λ,η>0. (6)

If someone has a few information about parameters, then informative priors may be used for Bayesian analysis. It is noted that FD converts an inverse exponential distribution if its shape parameter equal to 1 and takes the form of the inverse Rayleigh distribution for shape parameter equal to 2, and when shape equal to 0.5, it approximates the inverse gamma distribution. So, we consider gamma prior for the scale parameter by assuming that shape parameter is known and independent priors for the shape and location parameters. Thus the proposed prior is

π1α1α,α>0,π2η1η,η>0,π3λbaλa1ebλΓa,λ>0,a,b>0. (7)

The joint prior distribution of parameters α, λ, and η is

πα,λ,ηbaλa1ebλαηΓa,α,λ,η>0,a,b>0. (8)

The joint posterior density can be written as

Φα,λ,ηx=Lα,λ,ηx×πα,λ,ηα,λ,ηLα,λ,ηx×πα,λ,η×dαdλdη. (9)

Posterior distribution (9) takes a ratio form that cannot be reduced to a closed form. Therefore, we use Lindley's approximation [22] to get the Bayesian estimate, which can be written as

Ix=u+u1b1+u2b2+u3b3+b4+b5+12Λ1u1σ11+u2σ12+u3σ13+12Λ2u1σ21+u2σ22+u3σ23+12Λ3u1σ31+u2σ32+u3σ33. (10)

The detail of equation (10) is given in Appendix. Therefore, the approximate Bayesian estimators of parameters α, λ, and η by using noninformative prior under LINEX loss function are

α^BLNP=α^1k2log1k21α^σ111λ^σ121η^σ13k22σ11+12Λ1σ11+Λ2σ21+Λ3σ31,λ^BLNP=λ^1k2log1k21α^σ211λ^σ221η^σ23k22σ22+12Λ1σ12+Λ2σ22+Λ3σ32,η^BLNP=η^1k2log1k21α^σ311λ^σ321η^σ33k22σ33+12Λ1σ13+Λ2σ23+Λ3σ33. (11)

Bayesian estimators of parameters α, λ, and η with gamma prior under LINEX loss function are

α^BLGP=α^1k2log1k21α^σ11+a1λ^bσ121η^σ13k22σ11+12Λ1σ11+Λ2σ21+Λ3σ31,λ^BLGP=λ^1k2log1k21α^σ21+a1λ^bσ221η^σ23k22σ22+12Λ1σ12+Λ2σ22+Λ3σ32,η^BLGP=η^1k2log1k21α^σ31+a1λ^bσ321η^σ33k22σ33+12Λ1σ13+Λ2σ23+Λ3σ33. (12)

Similarly, Bayesian estimators of α, λ, and η using noninformative prior under GELF are

α^BGENP=α^k21k2α^1α^σ111λ^σ121η^σ13k2+12α^σ11+12Λ1σ11+Λ2σ21+Λ3σ311/k2,λ^BGENP=λ^k21k2λ^1α^σ211λ^σ221η^σ23k2+12λ^σ22+12Λ1σ12+Λ2δ22+Λ3σ321/k2,η^BGENP=η^k21k2η^1α^σ311λ^σ321η^σ33k2+12η^σ33+12Λ1σ13+Λ2δ23+Λ3σ331/k2. (13)

Bayesian estimators of parameters α, λ, and η with gamma prior under GELF are

α^BGEGP=α^k21k2α^1α^σ11+a1λ^bσ121η^σ13k2+12α^σ11+12Λ1σ11+Λ2σ21+Λ3σ311/k2,λ^BGEGP=λ^k21k2λ^1α^σ21+a1λ^bσ221η^σ23k2+12λ^σ22+12Λ1σ12+Λ2δ22+Λ3σ321/k2,η^BGEGP=η^k21k2η^1α^σ31+a1λ^bσ321η^σ33k2+12η^σ33+12Λ1σ13+Λ2δ23+Λ3σ331/k2, (14)

where α^, λ^, and η^ are the ML estimates of parameters α, λ, and η, respectively. Further, the observed Fisher information matrix is obtained by taking the second and mixed partial derivatives of equation (4) with respect to parameters α, λ, and η, respectively, provided in Appendix.

4. Simulation Study

To demonstrate the performance of the proposed Bayesian estimators with their ML counterpart in terms of biases and MSE (within parenthesis), different sample sizes and different values of parameters are considered using Monte Carlo simulation. Monte Carlo simulation is conducted as follows:

  1. Take the initial values of α, λ, and η, respectively. Samples are generated from the FD using inverse transformation technique, i.e., X(F)=η+λ(−ln U)−(1/α), where U is uniformly distributed random variable over the interval of [0, 1] and considering x > η.

  2. Calculate the ML and Bayesian estimators of g(α, λ, η) by 1/Ri=1 R g(α i, λ i, η i), where g(α i, λ i, η i) is the function of α, λ, and η using informative and noninformative priors and R is the number of iterations.

  3. The process is replicated 3000 times for each sample size and averages of these estimates and the corresponding MSEs (within parenthesis) were calculated for each method.

The results are listed in Tables 14 for comparison purposes. Table 1 contains simulation results for the case where α=1, λ=2, and η=3, and Table 2 presents the simulation results when α=1, λ=1, and η=4. Moreover, Tables 3 and 4 comprise the results for the case where α=0.5, λ=1.5, and η=3 and α=1, λ=2, and η=4, respectively. From the results of the simulation study, conclusions are drawn regarding the behavior of the estimators, which are summarized below:

  1. MSE decreases for both ML and Bayesian method when the sample sizes increases.

  2. In terms of MSE, the BGENP estimator provides the smallest MSE for all samples sizes and different values of parameters.

  3. Apparently, Bayesian and MLEs become better when the sample size increases. However, similar performance can be observed for large sample sizes.

  4. Based on simulation study and real data analysis, we suggest that the BGENP estimators in each scenario execute considerably, because the MSE is significantly smaller.

Table 1.

Average estimates for α=1, λ=2, and η=3 and MSEs (within parenthesis).

n Methods α=1 λ=2 η=3
25 ML 1.0846 (0.2084) 2.1346 (1.0679) 2.9279 (0.4305)
BLNP 0.9628 (0.1912) 1.9780 (1.0348) 2.8178 (0.4774)
BGENP 1.0412 (0.1562) 1.9997 (0.8626) 2.8577 (0.4294)
BLGP 0.9616 (0.1911) 1.9777 (1.0345) 2.8172 (0.4779)
BGEGP 0.9589 (0.1768) 1.8765 (0.9230) 2.7209 (0.4913)

50 ML 1.0066 (0.0455) 1.9707 (0.2594) 3.0378 (0.0710)
BLNP 0.9054 (0.0514) 1.8329 (0.2807) 2.9466 (0.0768)
BGENP 0.9818 (0.0423) 1.8764 (0.2473) 2.9920 (0.0628)
BLGP 0.9042 (0.0516) 1.8328 (0.2807) 2.9459 (0.0770)
BGEGP 0.9080 (0.0452) 1.7590 (0.2697) 2.8678 (0.0927)

70 ML 0.9956 (0.0269) 1.9795 (0.1822) 3.0394 (0.0569)
BLNP 0.9035 (0.0344) 1.8503 (0.2008) 2.9569 (0.0605)
BGENP 0.9763 (0.0258) 1.8987 (0.1769) 3.0038 (0.0474)
BLGP 0.9023 (0.0346) 1.8500 (0.2008) 2.9561 (0.0606)
BGEGP 0.9063 (0.0309) 1.7827 (0.2000) 2.8909 (0.0717)

100 ML 1.0127 (0.0212) 2.0353 (0.1197) 3.0051 (0.0386)
BLNP 0.9296 (0.0246) 1.9157 (0.1235) 2.9306 (0.0456)
BGENP 0.9975 (0.0201) 1.9672 (0.1116) 2.9778 (0.0302)
BLGP 0.9284 (0.0248) 1.9154 (0.1235) 2.9299 (0.0457)
BGEGP 0.9307 (0.0225) 1.8522 (0.1236) 2.8773 (0.0568)

MLE: maximum likelihood estimator; BLNP: Bayesian estimator under LINEX loss function with noninformative prior; BGENP: Bayesian estimator under general entropy loss function with noninformative prior; BLGP: Bayesian estimator under LINEX loss function with gamma prior; BGEGP: Bayesian estimator under general entropy loss function with gamma prior.

Table 2.

Average estimates for α=1, λ=1, and η=4 and MSEs (within parenthesis).

n Methods α=1 λ=1 η=4
25 ML 1.0686 (0.2168) 1.0192 (0.3295) 3.9716 (0.1756)
BLNP 0.9475 (0.2033) 0.8892 (0.3356) 3.8863 (0.1969)
BGENP 1.0262 (0.1669) 0.9649 (0.2828) 3.9189 (0.1682)
BLGP 0.9477 (0.2030) 0.8893 (0.3355) 3.8864 (0.1971)
BGEGP 0.94626 (0.1859) 0.8966 (0.3014) 3.7904 (0.2299)

50 ML 1.0005 (0.0434) 1.0020 (0.0799) 4.0227 (0.0185)
BLNP 0.8994 (0.0507) 0.8890 (0.0888) 3.9533 (0.0222)
BGENP 0.9759 (0.0406) 0.9620 (0.0749) 3.9905 (0.0180)
BLGP 0.8994 (0.0506) 0.8890 (0.0887) 3.9533 (0.0222)
BGEGP 0.9036 (0.0444) 0.8946 (0.0765) 3.8876 (0.0360)

70 ML 1.0070 (0.0294) 0.9931 (0.0457) 4.0136 (0.0149)
BLNP 0.9147 (0.0347) 0.8897 (0.0564) 3.9524 (0.0184)
BGENP 0.9873 (0.0277) 0.9606 (0.0444) 3.9897 (0.0147)
BLGP 0.9147 (0.0346) 0.8897 (0.0564) 3.9525 (0.0184)
BGEGP 0.9179 (0.0310) 0.8952 (0.0495) 3.9023 (0.0277)

100 ML 0.9807 (0.0112) 0.9672 (0.0335) 4.0253 (0.0078)
BLNP 0.8987 (0.0204) 0.8735 (0.0470) 3.9735 (0.0086)
BGENP 0.9664 (0.0110) 0.9414 (0.0330) 4.0084 (0.0076)
BLGP 0.8988 (0.0203) 0.8735 (0.0470) 3.9735 (0.0086)
BGEGP 0.9027 (0.0186) 0.8795 (0.0420) 3.9383 (0.0128)

Table 3.

Average estimates for α=0.5, λ=1.5, and η=3 and MSEs (within parenthesis).

n Methods α=0.5 λ=1.5 η=3
25 ML 0.4943 (0.0169) 1.3949 (0.5350) 3.0601 (0.0211)
BLNP 0.3977 (0.0256) 1.2209 (0.5768) 2.9876 (0.0212)
BGENP 0.4804 (0.0159) 1.2765 (0.4703) 3.0285 (0.0210)
BLNP 0.3966 (0.0259) 1.2207 (0.5766) 2.9868 (0.0212)
BGEGP 0.4379 (0.0171) 1.1824 (0.4775) 2.9268 (0.0310)

50 ML 0.4937 (0.0058) 1.5372 (0.2661) 3.0213 (0.0063)
BLNP 0.4137 (0.0127) 1.3767 (0.2674) 2.9607 (0.0088)
BGENP 0.4849 (0.0057) 1.4323 (0.2274) 3.0012 (0.0062)
BLGP 0.4122 (0.0130) 1.3765 (0.2674) 2.9595 (0.0089)
BGEGP 0.4450 (0.0077) 1.3285 (0.2282) 2.9166 (0.0161)

70 ML 0.4946 (0.0033) 1.4658 (0.1306) 3.0220 (0.0033)
BLNP 0.4232 (0.0089) 1.3162 (0.1576) 2.9696 (0.0044)
BGENP 0.4877 (0.0030) 1.3800 (0.1264) 3.0073 (0.0031)
BLGP 0.4220 (0.0091) 1.3160 (0.1575) 2.9686 (0.0045)
BGEGP 0.4500 (0.0053) 1.2795 (0.1485) 2.9364 (0.0084)

100 ML 0.5030 (0.0025) 1.4499 (0.1150) 3.0166 (0.0018)
BLNP 0.4401 (0.0059) 1.3114 (0.1424) 2.9719 (0.0027)
BGENP 0.4977 (0.0024) 1.3777 (0.1136) 3.0060 (0.0017)
BLGP 0.4389 (0.0060) 1.3113 (0.1423) 2.9711 (0.0028)
BGEGP 0.4621 (0.0036) 1.2789 (0.1366) 2.9477 (0.0052)

Table 4.

Average estimates for α=1, λ=2, and η=4 and MSEs (within parenthesis).

n Methods α=1 λ=2 η=4
25 ML 1.0071 (0.2034) 1.9144 (0.9570) 4.0738 (0.4348)
BLNP 0.8881 (0.2050) 1.7585 (0.9943) 3.9681 (0.4455)
BGENP 0.9680 (0.1688) 1.7917 (0.8742) 3.9883 (0.4324)
BLGP 0.8870 (0.2052) 1.7583 (0.9942) 3.9675 (0.4457)
BGEGP 0.8908 (0.1781) 1.6776 (0.8783) 3.8290 (0.4487)

50 ML 0.9946 (0.0536) 1.9231 (0.2714) 4.0420 (0.0857)
BLNP 0.8938 (0.0613) 1.7856 (0.3072) 3.9522 (0.0916)
BGENP 0.9701 (0.0503) 1.8314 (0.2703) 3.9861 (0.0854)
BLGP 0.8927 (0.0615) 1.7853 (0.3072) 3.9515 (0.0918)
BGEGP 0.8971 (0.0538) 1.7163 (0.3013) 3.8479 (0.1183)

70 ML 0.9767 (0.0263) 1.9316 (0.2179) 4.0576 (0.0562)
BLNP 0.8854 (0.0371) 1.8029 (0.2470) 3.9761 (0.0567)
BGENP 0.9580 (0.0259) 1.8523 (0.2161) 4.0141 (0.0558)
BLGP 0.8842 (0.0374) 1.8029 (0.2470) 3.9754 (0.0567)
BGEGP 0.8893 (0.0335) 1.7384 (0.2461) 3.8896 (0.0716)

100 ML 1.0186 (0.0240) 2.0271 (0.1457) 3.9930 (0.0470)
BLNP 0.9354 (0.0263) 1.9079 (0.1512) 3.9188 (0.0563)
BGENP 1.0034 (0.0225) 1.9596 (0.1372) 3.9593 (0.0405)
BLGP 0.9341 (0.0264) 1.9076 (0.1512) 3.9181 (0.0564)
BGEGP 0.9362 (0.0240) 1.8451 (0.1490) 3.8493 (0.0752)

5. Data Analysis

For exemplification purposes, the data set presented in Table 5 reported by Efron [23] represents the survival times of a group of patients suffering from head and neck cancer and treated using a combination of radiotherapy and chemotherapy. The data set consists of 44 observations.

Table 5.

Survival times of a group of patients suffering from head and neck cancer.

12.20 23.56 23.74 25.87 31.98 37 41.35 47.38 55.46 58.36 63.47
68.46 78.26 74.47 81.43 84 92 94 110 112 119 127
130 133 140 146 155 159 173 179 194 195 209
249 281 319 339 432 469 519 633 725 817 1776

Parametric analysis is performed to determine the best-fitted probability distribution function that characterizes the survival times of a group of patients suffering from head and neck cancer. The distribution in Figure 1 is highly skewed to the right. The distribution curve is asymmetric being stretched out to the right. Among the skewed distributions, FD is fitted to survival times of a group of patients suffering from head and neck cancer, parameters are estimated by using ML and Bayesian methods, and the results are presented in Table 6 for comparison purposes. The Kolmogorov–Smirnov (KS) test along with P values is used to quantify the model. Further, P values of KS test are significant at 5% level of significance except BLGP, which may indicate that the rest of the estimators are most appropriate for estimating the parameter of FD. Moreover, different estimates can also be visualized in Figure 1, in which the x-axis represents the survival times of a group of patients suffering from head and neck cancer while the Frechet density function of survival is taken on the y-axis.

Figure 1.

Figure 1

Comparison of estimation methods.

Table 6.

Goodness of fit test.

Methods Estimators KS test
α λ η D P value
ML 1.5292 120.7537 −33.62417 0.0553 0.9982
BLNP 1.1071 519.9316 −37.7096 0.1098 0.6236
BGENP 1.4870 114.8435 −35.1019 0.0843 0.8865
BLGP 0.6747 114.6567 −39.13914 0.2043 0.0435
BGEGP 0.9497 93.2270 −35.9787 0.1936 0.0641

6. Conclusion and Recommendations

Statistical decision theory addresses the state of uncertainty and provides a rational framework for dealing problems of medical decision-making. The Bayesian paradigm represents the probabilistic relationships between diseases and symptoms. Although medical data are generally skewed to the right, positively skewed distributions are reasonably competitive when describing unimodal medical data. In this study, an attempt has been made to examine the Bayesian estimators for three-parameter FD with medical applications. The Bayesian estimators are obtained using LINEX and GE loss functions considering gamma and noninformative priors through Lindley approximation. It is concluded that BGENP performed quite well in estimating the parameters of FD in terms of MSE as compared to other estimators. However, Bayesian and MLEs get closer in terms of MSEs for larger sample sizes. Though computation of Lindley's method is based on the MLEs, it performs well for various sample sizes. The speed of convergence of Lindley's method is so fast for all problems and may rely on initial points. Based on these findings, it can be safely concluded that parametric FD is most suitable for describing the medical related data.

The study will offer a framework for testing features of other skewed distributions considering Bayesian framework with medical data. Thus, providing a more detailed and accurate understanding of the distribution of medical data and professionals can make decisions on rational bases. Moreover, the problem of Bayes estimation for three-parameter FD can be extended to include informative priors and also to consider other techniques such as MCMC (Markov Chain Monte Carlo) methods, and Laplace approximation can be used to get the posterior summaries, investigate their performances, and compare them with those of the MLEs.

Acknowledgments

We express our thanks to Dr. Muhammad Taj, Assistant Professor of Mathematics, for reviewing the mathematical work.

Appendix

The observed Fisher information matrix can be written as

Iα,λ,η=2Łα22Łαλ2Łαη2Łλα2Łλ22Łλη2Łηα2Łηλ2Łη2, (A.1)

where

2Lα2=nα2i=1nxiηλαlog2xiηλ,2Lαλ=nλ+αλi=inxiηλαlogxiηλ1λi=1nxiηλα,2Lαη=i=1n1xiη+αλi=1nxiηλα1logxiηλi=1nxiηλαxiη1,2Lλα=nλ+αλi=inxiηλαlogxiηλ1λi=1nxiηλα,2Lλ2=nαλαα1λ2i=1nxiηλα,2Lλη=α2λi=1nxiηλα+1,2Lηα=i=1n1xiη+αλi=1nxiηλα1logxiηλ1λi=1nxiηλα1,2Lηλ=α2λi=1nxiηλα+1,2Lη2=α+1i=1n2xiηαα1λ2i=1nxiηλα1. (A.2)

From equation (10), we have

Λ1=σ11Lααα+2σ12Lαλα+2σ13Lαηα+2σ23Lληα+σ22Lλλα+σ33Lηηα,Λ2=σ11Lααλ+2σ12Lαλλ+2σ13Lαηλ+2σ23Lληλ+σ22Lλλλ+σ33Lηηλ,Λ3=σ11Lααη+2σ12Lαλη+2σ13Lαηη+2σ23Lληη+σ22Lλλη+σ33Lηηη, (A.3)

and for i=1,2,3,

bi=τ1σi1+τ2σi2+τ3σi3,b4=u12σ12+u13σ13+u23σ23,b5=12u11σ11+u22σ22+u33σ33,τi=τϕi,i=1,2,ui=uϕ1,ϕ2,ϕ3ϕi,i=1,2,uij=u2ϕ1,ϕ2,ϕ3ϕi,ϕj,i,j=1,2,Łij=u2ϕ1,ϕ2,ϕ3ϕiϕj,i,j=1,2,Łijk=u3ϕ1,ϕ2,ϕ3ϕiϕjϕk,i,j,k=1,2,3,σij=1Łij. (A.4)

Moreover, u(ϕ 1, ϕ 2, ϕ 3) represents the first, second, and third parameter, respectively. τ i denotes the derivatives of log of prior w.r.t. ϕ 1, ϕ 2, and ϕ 3. Ł ij inverse of Fisher information and Ł ijk are third derivatives obtained from equation (4).

The values of L ijk used in Lindley's approximation are given as

Łααα=2nα3+i=1nxiηλα×log3xiηλ,Łλλλ=2nαλ3αα1α2λ3i=1nxiηλα,Łηηη=2α+1i=1n1xiηαα+1α+2λ3i=1nxiηλα+3,Łληη=Łηλη=Łηηλ=α2α+1δ3i=1nxiλλα+2,Łλλη=Łληλ=Łηλλ=α2α1λ3i=1nxiηλα+1,Łααλ=2λi=inxiηλα× logxiηλαλi=1nxiηλα×log2xiηλ=Łαλα=Łλαα,Łαηλ=α2λ2i=1nxiηλα+1× logxiηλ2αλ2i=1nxiηλα+1=Łηαλ=Łλαη=Łαλη=Łληα=Łηλα,Łααη=Łαηα=Łηαα=αλi=1nxiηλα+1×log2xiηλ+2λi=1nxiηλα1× logxiηλ,Łαλλ=Łλαλ=Łλλα=nλ2+α2λ2i=1nxiηλαlogxiηλαλ2i=1nxiηλα× logxiηλ2αλ2i=1nxiηλα+1λ2i=1nxiηλα,Łαηη=Łηαη=Łηηα=i=1nxiη2+α2λ2i=1nxiηλα+2logxiηλ+αλ2i=1nxiηλα+2logxiηλ1λ2i=1nxiηλα+22αλ2i=1nxiηλα+2. (A.5)

Data Availability

Our work is mainly a methodological development and has been applied on secondary data, but if required, data will be provided.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.

References

  • 1.Frechet M. Sur la loi de probabilite de lecart maximum. Annales Polonici Mathematici. 1927;6(93):110–116. [Google Scholar]
  • 2.Gumbel E. J. A quick estimation of the parameters in Frechet’s distribution. Revue de l’Institut International de Statistique/Review of the International Statistical Institute. 1965;33(3):349–363. doi: 10.2307/1401700. [DOI] [Google Scholar]
  • 3.Mann R. N. Statistical estimation of parameters of the Weibull and Frechet distribution. In: Tiago de oliveira J., editor. Statististical Extremes and Applications. Dordrecht, Netherlands: Springer; 1984. pp. 81–89. [Google Scholar]
  • 4.Singh N. P. Maximum likelihood estimation of Frechet distribution parameters. Journal of Statistical Studies. 1987;7(2):11–28. [Google Scholar]
  • 5.Hooda B. K., Singh N. P., Singh U. On estimation in Frechet distribution of m-th maxima. Communications in Statistics-Theory and Methods. 1993;22(3):907–919. doi: 10.1080/03610929308831064. [DOI] [Google Scholar]
  • 6.Afify E. D. On the confidence interval of the Frechet distribution. Far East Journal of Theoretical Statistics. 2004;12(2):221–226. [Google Scholar]
  • 7.Mubarak M. Estimation of the Frechet distribution parameters on the record values. Arabian Journal for Science and Engineering. 2011;36(8):1597–1606. doi: 10.1007/s13369-011-0137-6. [DOI] [Google Scholar]
  • 8.Mubarak M. Parameter estimation based on the frèchet progressive type II censored data with binomial removals. International Journal of Quality, Statistics, and Reliability. 2012;2012:5. doi: 10.1155/2012/245910.245910 [DOI] [Google Scholar]
  • 9.Abbas K., Tang Y. Comparison of estimation methods for Frechet distribution with known shape. Caspian Journal of Applied Sciences Research. 2012;1(10):58–64. [Google Scholar]
  • 10.Abbas K., Tang Y. Estimation of parameters of Frechet distribution based on type II cesored samples. Caspian Journal of Applied Sciences Research. 2013;2(7):36–43. [Google Scholar]
  • 11.Abbas K., Tang Y. Objective Bayesian analysis of the Frechet stress-strength model. Statistics & Probability Letters. 2014;84:169–175. doi: 10.1016/j.spl.2013.09.014. [DOI] [Google Scholar]
  • 12.Abbas K., Tang Y. Analysis of Frechet distribution using reference priors. Communications in Statistics-Theory and Methods. 2015;44(14):2945–2956. doi: 10.1080/03610926.2013.802351. [DOI] [Google Scholar]
  • 13.Nasir W., Aslam M. Bayes approach to study shape parameter of Frechet distribution. International Journal of Basic and Applied Sciences. 2015;4(3):246–254. doi: 10.14419/ijbas.v4i3.4644. [DOI] [Google Scholar]
  • 14.Battiti R., Masulli F. BFGS optimization for faster and automated supervised learning. Proceedings of International Neural Network Conference; July 1990; Dordrecht, Netherlands. Springer; pp. 757–760. [DOI] [Google Scholar]
  • 15.Varian H. R. Bayesian approach to real estate assessment. In: Fienberg S. E., Zellner A., editors. Bayesian Econometrics and Statistics. Amsterdam, Netherlands: North Holland Publishing Co.; 1975. pp. 195–208. [Google Scholar]
  • 16.Rojo J. On the admissibility of cX¯+d with respect to the LINEX loss function. Communications in Statistics-Theory and Methods. 1987;16(12):3745–3748. doi: 10.1080/03610928708829603. [DOI] [Google Scholar]
  • 17.Basu A. P., Ebrahimi N. Bayesian approach to life testing and reliability estimation using asymmetric loss function. Journal of Statistical Planning and Inference. 1991;29(1-2):21–31. doi: 10.1016/0378-3758(92)90118-c. [DOI] [Google Scholar]
  • 18.Pandey B. N. Estimator of the scale parameter of the exponential distribution using LINEX loss function. Communications in Statistics-Theory and Methods. 1997;26(9):2191–2202. [Google Scholar]
  • 19.Soliman A. A. Estimation of parameters of life from progressively censored data using Burr XII model. IEEE Transactions on Reliability. 2005;54(1):34–42. doi: 10.1109/tr.2004.842528. [DOI] [Google Scholar]
  • 20.Soliman A. A., Abd-Ellah A. H., Sultan K. H. Comparison of estimates using record statistics from Weibull model: Bayesian and non-Bayesian approaches. Computational Statistics & Data Analysis. 2006;51(3):2065–2077. doi: 10.1016/j.csda.2005.12.020. [DOI] [Google Scholar]
  • 21.Calabria R., Pulcini G. Point estimation under asymmetric loss functions for left truncated exponential samples. Communications in Statistics-Theory and Methods. 1996;25(3):585–602. doi: 10.1080/03610929608831715. [DOI] [Google Scholar]
  • 22.Lindley D. V. Approximate bayesian method. Trabajos de Estadistica Y de Investigacion Operativa. 1980;31(1):223–237. doi: 10.1007/bf02888353. [DOI] [Google Scholar]
  • 23.Efron B. Logistic regression, survival analysis, and the kaplan-meier curve. Journal of the American Statistical Association. 1988;83(402):414–425. doi: 10.2307/2288857. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Our work is mainly a methodological development and has been applied on secondary data, but if required, data will be provided.


Articles from Computational and Mathematical Methods in Medicine are provided here courtesy of Wiley

RESOURCES